How To Deal With Colon Cancer
One of the many aggressive and disastrous forms of cancer is neuroendocrine carcinoma of colon. The worst part of this disease is that it is usually detected in it’s late stages at which time it is more difficult to make treatments.
As the effects of neuroendocrine colon cancer become visible only in the most advanced stages the rate of survival of the patient drops drastically The tumors are always malignant, and mostly detected with distant metastases. Surveys show reports reveal that most of the cases of neuroendocrine cancer end with the death of the patient.
Though the possibilities of neuroendocrine carcinoma in colon are very rare, if unfortunately one is affected by this disease, the health of the patient becomes worse than patients who suffer from adenocarcinoma.
Research reveals that the final results of this cancer stay the same with age, sex or tumor location. Though neuroendocrine colon carcinoma depends on which stage the tumor is in The usual trends reveal that most peopleshow that generally people in stage 1 and 2 of cancer usually do not suffer from neuroendocrine colon cancer. But alternately in the majority of cases if the tumor is in stage 3 or 4, it is a laborious and hard task the neuroendocrine colon carcinoma.
Unfortunately, medical science has developed no adequate methods to deal with this particular cancer. A more common technique that doctors might use is immunohistochemical staining methods. this method assists doctors in dealing with the severity of the neuroendocrine colon cancer and helps to determine the most helpful medication and treatment for it. Immunohistochemical staining methods is specifically used for neuroendocrine markers. It involves the staining of the tumor with a monoclonal antibody A-80 which will help in the identification of the quantum of neuroendocrine differentiation and nature of the damage on the health of the patient.
Neuroendocrine colon carcinoma is difficult to treat and in a certain study in which a number of patients suffered from this particular disease underwent examination and, it was noted that the overall survival rate for this disease was only about seven months. In the later stages these rates decrease, to as low as five months or less. The great majority of these cases were originally seen as carcinoids but they later developed in to neuroendocrine colon carcinoma. Neuroendocrine colon cancer does not have a good prognosis and surgery is not always a perfect or even viable treatment so surgery may not provide a satisfactory cure. Therefore it becomes necessary to notice the presence of this disease quickly and prescribe the right medication.
